Munveer S. Bhangoo

775 total citations
27 papers, 563 citations indexed

About

Munveer S. Bhangoo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Munveer S. Bhangoo has authored 27 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Munveer S. Bhangoo's work include Prostate Cancer Treatment and Research (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Lung Cancer Research Studies (3 papers). Munveer S. Bhangoo is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Lung Cancer Research Studies (3 papers). Munveer S. Bhangoo collaborates with scholars based in United States, Spain and South Korea. Munveer S. Bhangoo's co-authors include Darren Sigal, José G. Montoya, Siraj M. Ali, Jason Cham, Miguel Reina‐Campos, Mitchell R. Lunn, Antoine L’Hermitte, Ángeles Durán, Tessa M.F. Watt and María T. Díaz‐Meco and has published in prestigious journals such as Journal of Clinical Oncology, Immunity and Cancer Cell.

In The Last Decade

Munveer S. Bhangoo

26 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Munveer S. Bhangoo United States 12 195 164 162 110 105 27 563
Masayo Tsukamoto Japan 13 150 0.8× 115 0.7× 297 1.8× 112 1.0× 86 0.8× 36 612
H. Wang United States 8 184 0.9× 109 0.7× 206 1.3× 92 0.8× 65 0.6× 21 614
Masahiro Shimokawa Japan 11 158 0.8× 97 0.6× 102 0.6× 118 1.1× 97 0.9× 25 454
Małgorzata Fuksiewicz Poland 14 170 0.9× 70 0.4× 321 2.0× 81 0.7× 88 0.8× 42 620
Jon D. Dorfman United States 9 180 0.9× 77 0.5× 168 1.0× 77 0.7× 38 0.4× 20 439
Manabu Shimomura Japan 14 245 1.3× 182 1.1× 298 1.8× 123 1.1× 40 0.4× 67 805
Yongjie Shui China 15 207 1.1× 154 0.9× 206 1.3× 75 0.7× 62 0.6× 32 648
Kazuhiko Fukumoto Japan 12 99 0.5× 169 1.0× 155 1.0× 85 0.8× 103 1.0× 31 576
Erdem Çubukçu Türkiye 12 106 0.5× 75 0.5× 253 1.6× 103 0.9× 59 0.6× 51 481

Countries citing papers authored by Munveer S. Bhangoo

Since Specialization
Citations

This map shows the geographic impact of Munveer S. Bhangoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Munveer S. Bhangoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Munveer S. Bhangoo more than expected).

Fields of papers citing papers by Munveer S. Bhangoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Munveer S. Bhangoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Munveer S. Bhangoo. The network helps show where Munveer S. Bhangoo may publish in the future.

Co-authorship network of co-authors of Munveer S. Bhangoo

This figure shows the co-authorship network connecting the top 25 collaborators of Munveer S. Bhangoo. A scholar is included among the top collaborators of Munveer S. Bhangoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Munveer S. Bhangoo. Munveer S. Bhangoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
New, Jacob, et al.. (2024). Pluvicto in the real world setting and timing to PSA50 as a predictive marker of treatment response.. Journal of Clinical Oncology. 42(16_suppl). e17026–e17026. 1 indexed citations
2.
Elliot, Mark, et al.. (2024). AN EX-VIVO SPECTRAL AND LIFETIME-DECAY ANALYSIS OF 5-ALA DERIVED PPIX flUORESCENCE: OBJECTIVE flUORESCENCE MAPPING IN GLIOMA SURGERY. Neuro-Oncology. 26(Supplement_7). vii8–vii9. 1 indexed citations
3.
Cham, Jason, et al.. (2023). A review of treatments targeting DNA-repair gene defects in metastatic castration resistant prostate cancer. Frontiers in Oncology. 13. 1150777–1150777. 2 indexed citations
4.
Bhangoo, Munveer S., et al.. (2022). Long-term outcomes of elderly hairy cell leukemia patients treated with cladribine. Annals of Hematology. 101(5). 1089–1096.
5.
Sigal, Darren, Munveer S. Bhangoo, Catherine Frenette, et al.. (2022). A phase 1 study of ABX196 in combination with nivolumab in patients with previously treated hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 40(4_suppl). 429–429. 2 indexed citations
6.
Cham, Jason, et al.. (2021). Malignant Melanoma With Neuroendocrine Differentiation: A Case Report and Literature Review. Frontiers in Oncology. 11. 763992–763992. 4 indexed citations
7.
Cham, Jason, et al.. (2021). Targeting the PI3K-AKT-mTOR Pathway in Castration Resistant Prostate Cancer: A Review Article. Clinical Genitourinary Cancer. 19(6). 563.e1–563.e7. 32 indexed citations
8.
Reina‐Campos, Miguel, Juan F. Linares, Ángeles Durán, et al.. (2019). Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer. Cancer Cell. 35(3). 385–400.e9. 148 indexed citations
9.
Bhangoo, Munveer S., et al.. (2018). Tumor Mutational Burden Guides Therapy in a Treatment Refractory POLE-Mutant Uterine Carcinosarcoma. The Oncologist. 23(5). 518–523. 45 indexed citations
10.
Nicholson, Laura, et al.. (2018). 223P Sarcomatoid lung carcinoma: An uncommon and deadly entity. Journal of Thoracic Oncology. 13(4). S134–S134. 2 indexed citations
11.
Bhangoo, Munveer S., et al.. (2018). Predictors of Change in the Ankle Brachial Index with Exercise. European Journal of Vascular and Endovascular Surgery. 55(3). 399–404. 15 indexed citations
12.
Nakanishi, Yuki, Ángeles Durán, Antoine L’Hermitte, et al.. (2018). Simultaneous Loss of Both Atypical Protein Kinase C Genes in the Intestinal Epithelium Drives Serrated Intestinal Cancer by Impairing Immunosurveillance. Immunity. 49(6). 1132–1147.e7. 41 indexed citations
13.
Bhangoo, R.S., Munveer S. Bhangoo, Aaron R. Mangold, & William W. Wong. (2018). Radiation Recall Dermatitis After the Use of Pralatrexate for Peripheral T-cell Lymphoma. Advances in Radiation Oncology. 4(1). 31–34. 2 indexed citations
14.
Klempner, Samuel J., Munveer S. Bhangoo, Hubert Y. Luu, et al.. (2018). Low ATM expression and progression-free and overall survival in advanced gastric cancer patients treated with first-line XELOX chemotherapy. Journal of Gastrointestinal Oncology. 9(6). 1198–1206. 6 indexed citations
15.
16.
Bhangoo, Munveer S., et al.. (2015). Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma.. PubMed. 6(5). 469–78. 53 indexed citations
17.
Bhangoo, Munveer S., et al.. (2014). Spontaneous subdural haemorrhage in a patient with scleroderma renal crisis. BMJ Case Reports. 2014. bcr2014205471–bcr2014205471. 4 indexed citations
18.
Montoya, José G., Andreas M. Kogelnik, Munveer S. Bhangoo, et al.. (2013). Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. Journal of Medical Virology. 85(12). 2101–2109. 58 indexed citations
19.
Watt, Tessa M.F., et al.. (2012). Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein–Barr virus IgG antibody titers. Journal of Medical Virology. 84(12). 1967–1974. 31 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masayo Tsukamoto Breakdown of academic impact, for papers by H. Wang Breakdown of academic impact, for papers by Masahiro Shimokawa Breakdown of academic impact, for papers by Małgorzata Fuksiewicz Breakdown of academic impact, for papers by Jon D. Dorfman Breakdown of academic impact, for papers by Manabu Shimomura Breakdown of academic impact, for papers by Yongjie Shui Breakdown of academic impact, for papers by Kazuhiko Fukumoto Breakdown of academic impact, for papers by Erdem Çubukçu
Rankless by CCL
2026